MR-guided laser ablation proved as effective as surgery, the current standard of care, for the treatment of liver tumors in a study by University of Frankfurt researchers. The trial highlights the largest patient population and longest follow-up of its kind.
MR-guided laser ablation proved as effective as surgery, the current standard of care, for the treatment of liver tumors in a study by University of Frankfurt researchers. The trial highlights the largest patient population and longest follow-up of its kind.
Dr. Martin Mack and colleagues treated 2506 liver tumors with MR-guided laser-induced thermotherapy (LITT) between 1993 and 2005. They tracked patients' survival rates to evaluate the long-term effectiveness of the procedure.
The average survival rate of 3.8 years for patients treated with LITT compared favorably with that of surgery, which yielded a survival rate of approximately 1.5 to five years. Mack presented the findings at the 2005 RSNA meeting.
Interventionalists can offer LITT on an outpatient basis under local anesthesia. Patients spend only a few hours instead of weeks in the hospital after resection. Physicians can perform LITT simultaneously on both liver lobes and repeat treatment if they find new tumors at follow-up, which is virtually impossible by traditional surgical means, Mack said. He concluded that LITT is superior to resection in surgical candidates.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.